LB Pharmaceuticals’ public listing comes amid a dry spell for biotech IPOs despite a flurry of activity early in 2025.

The company, which is developing a competitor to Cobenfy, aims to become one of rare biotechs to price a large IPO of late.

MapLight Therapeutics, the second biotech to launch a Nasdaq bid this month, is a neuro-focused company advancing treatments ...

Sheel Biotech, specializing in biotechnology-driven agriculture solutions, announced its Rs 34.02 crore IPO. With a price ...

The initial public offering of Fabtech Technologies is set to open for public bidding today, September 29. The company aims ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other industries as biotechnology has delivered only subpar investor returns. Only five ...

So much for the dog days of summer. During July, 6 more biotech companies took a running leap through the wide-open IPO window, joining a growing pool of newly made ...

A couple of recent IPOs prompted huge insider buying. However, these were not the only notable insider purchases in the past week.

The U.S. IPO activity looks sluggish amid the holiday-shortened week. Nevertheless, the week prior saw Texas-based cybersecurity firm SailPoint price its upsized IPO of 60M shares at a public offering ...

Four mainboard and 16 SME IPOs open for subscription next week — explore key dates, listing info, and how to invest now!

Fabtech Technologies IPO opens today, Sept 29. Check key details including price band, lot size, grey market premium, listing ...